Halozyme Therapeutics Inc (HALO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Halozyme Therapeutics Inc   (NASDAQ: HALO)
 

Halozyme Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Halozyme Therapeutics Inc inventory turnover ratio, the Halozyme Therapeutics Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.13 in the third quarter 2026, HALO's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Halozyme Therapeutics Inc in Sep 30 2026 quarter, has decreased to 171 days, compare to 204 days, in the Jun 30 2026 quarter.

Within Healthcare sector 226 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 1442.

HALO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Halozyme Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HALO Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -28.62 % -24.45 % -5.7 % 24.4 % 41.38 %
Y / Y Cost of Sales Growth 49.3 % 70.78 % 63.7 % 87.3 % 11.77 %
Inventory Turnover Ratio (TTM) 2.13 1.79 1.49 1.29 1.14
HALO's Total Ranking # 1442 # 1442 # 1040 # 1129 #
Average inventory processing period 172 204 246 283 320
Seq. Inventory Growth -3.3 % -11.79 % -11.9 % -5.02 % 2.36 %
Seq. Cost of Sales Growth 4.17 % -0.08 % 0.59 % 42.59 % 19.16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 227
Overall Market # 1442

Inventory Turnover Ratio Statistics
High Average Low
3.64 1.73 0.23
(Jun 30 2015)   (Jun 30 2012)



HALO Company Profile >> Back to HALO Efficiency Comparisons >> Compare HALO Inventory Turnover Ratio to its Competitors

Financial Statements
Halozyme Therapeutics Inc 's Inventories $ 133 Millions Visit HALO's Balance sheet
Halozyme Therapeutics Inc 's Cost of Revenues TTM $ 320 Millions Visit HALO's Income Statement
What are HALO's Sales? Visit HALO's Sales by Segment

Other Inventory Turnover Ratios
Halozyme Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HALO's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HALO's Competitors
Inventory Turnover Ratio for HALO's Suppliers
Inventory Turnover Ratio for HALO's Customers

You may also want to know
HALO's Sales Growth Rates HALO's Pe Price to earnings ratio HALO's Receivables Turnover Ratio HALO's Stock Quote
HALO's Net Income Growth Rates HALO's Ps Price to Sales ratio HALO's Sales per Employee HALO's Asset Turnover Ratio
HALO's Net Margin HALO's Pb Price to Book ratio HALO's Financial Strength Ratios HALO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions

Date modified: 2026-11-08T13:40:15+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.